Corvus Pharmaceuticals Inc (CRVS)

1.64 +0.08 (+5.13%) USD  |  NASDAQ  |  May 01, 16:00
1.64 0.00 (0.00%) After-Hours: 19:54
More

Corvus Pharmaceuticals EV to EBITDA

EV to EBITDA Chart

View EV to EBITDA for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to EBITDA Data

View and export this data back to 2016. Upgrade now.
Date Value
March 30, 2016 --
March 29, 2016 --
March 28, 2016 --
Date Value
March 24, 2016 --
March 23, 2016 --

EV to EBITDA Definition

The EV to EBITDA measures the ratio between enterprise value and earnings before interest, taxes, depreciation, and amortization. This metric is important to analyze when looking at a company's true value based on how much they are valued at compared to how money they are earning.

Read full definition.

EV to EBITDA Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EV to EBITDA Benchmarks

Cyclacel Pharmaceuticals Inc --
Arbutus Biopharma Corp --
Oragenics Inc --
Relmada Therapeutics Inc --
MAIA Biotechnology Inc --

EV to EBITDA Related Metrics

EV to Free Cash Flow Upgrade